Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 74.30 +0.96%   SPY: 166.94 +0.97%
Quote Spy AMRN NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Amarin (AMRN)

@ May-17
Click the portfolio to add AMRN:
Close [X]
+ Add AMRN to Portfolio
  
  Last Trade: $7.14 -0.09 (-1.24%)
  Volume: 2,621,602 66% of avg daily volume
       
  Avg Volume: 3,960,367
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 7.08 - 7.39
  Open: 7.36
  Previous Close: 7.23
  52-wk Range: 6.34 - 15.96
  Market Cap: 1.0B
  P/E: -7.3
  Div Yield: $0.00 (0.00%)
Indexes
Biotechnology Stocks (+0.7%)
Nervous System Stock... (+1.6%)
United Kingdom Stock... (-0.2%)
Spy AMRN

? Pro holders
? Member holders
? Items submitted
Additional AMRN resources



Customize Links
To see which Pros and tickerspy members own AMRN Sign up now
Latest AMRN Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Photo Release -- Amarin Reports First Quarter 2013 Financial Results and Provides Update on Operations
AMRN  
Linked by GlobeNewswire - May 09, 04:13PM from (globenewswire.com)
BEDMINSTER, N.J., and DUBLIN, Ireland, May 9, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a late-stage  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Another Negative Fish Oil Study Adds To Amarin's Marketing Challenges
AMRN  SNY  GSK  LPDX  OMTH  
Linked by Investopedia Stock Analysis - May 09, 12:30PM from (www.investopedia.com)
More questions about the real efficacy of fish oil is bad news for Amarin.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Amarin to Report First Quarter 2013 Results and Host Conference Call on May 9, 2013
AMRN  
Linked by GlobeNewswire - May 03, 04:13PM from (globenewswire.com)
BEDMINSTER, N.J. and DUBLIN, May 3, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Amarin Announces Approval of Supplemental New Drug Application for BASF as Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier
AMRN  
Linked by GlobeNewswire - April 30, 06:13AM from (globenewswire.com)
BEDMINSTER, N.J. and DUBLIN, Ireland, April 30, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Amarin Announces FDA Acceptance of Supplemental New Drug Application (sNDA) for Vascepa(R) for the Treatment of Patients With High Triglycerides (>200 mg/dL and <500 mg/dL) With Mixed Dyslipidemia
AMRN  
Linked by GlobeNewswire - April 23, 06:13AM from (globenewswire.com)
BEDMINSTER, N.J. and DUBLIN, Ireland, April 23, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Amarin Announces Approval of Supplemental New Drug Application for Chemport as Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier
AMRN  
Linked by GlobeNewswire - April 18, 06:13AM from (globenewswire.com)
BEDMINSTER, N.J. and DUBLIN, Ireland, April 18, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Amarin Announces New Clinical Data Showing Significant Reductions in Apolipoprotein C-III Levels in MARINE and ANCHOR Studies of Vascepa(R)
AMRN  
Linked by GlobeNewswire - April 08, 06:13AM from (globenewswire.com)
BEDMINSTER, N.J., and DUBLIN, Ireland, April 8, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Amarin Reports Fourth Quarter and Year-End 2012 Financial Results and Provides Update on Operations
AMRN  
Linked by GlobeNewswire - February 28, 04:13PM from (globenewswire.com)
BEDMINSTER, N.J. and DUBLIN, Ireland, Feb. 28, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a late-stage  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Amarin Announces Submission of Supplemental New Drug Application (sNDA) for Vascepa(R) for the Treatment of Patients With High Triglycerides With Mixed Dyslipidemia
AMRN  
Linked by GlobeNewswire - February 26, 05:13AM from (globenewswire.com)
BEDMINSTER, N.J. and DUBLIN, Ireland, Feb. 26, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Amarin to Report Fourth Quarter and Year-End 2012 Results and Host Conference Call on February 28, 2013
AMRN  
Linked by GlobeNewswire - February 22, 04:13PM from (globenewswire.com)
BEDMINSTER, N.J., and DUBLIN, Ireland, Feb. 22, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 18



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource